Anixa Biosciences, Inc.
USD3.56
+0.10 (+2.89%)
CEO
Amit Kumar
IPO Date
1983-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.53
Prev. Close
$3.46
Day Low
$3.45
Day High
$3.69
52W Low
$2.32
52W High
$5.46
Market Cap
$0.12B
Volume
0.59M
| 5,000 |
| $3.04 |
| 17 Jun 2026 | Titterton Lewis H jr | director | P-Purchase | Acquired | 2,836 | $2.64 |
| 16 Jun 2026 | KUMAR AMIT | director, officer: Chief Executive Officer | P-Purchase | Acquired | 21,000 | $2.50 |
| 29 Jan 2026 | Baskies Arnold M | director | P-Purchase | Acquired | 10,000 | $3.04 |
| 6 Jan 2026 | Titterton Lewis H jr | director | A-Award | Acquired | 25,000 | $3.18 |
| 6 Jan 2026 | KUMAR AMIT | director, officer: Chief Executive Officer | A-Award | Acquired | 350,000 | $3.18 |
| 6 Jan 2026 | Gottschalk Emily | director | A-Award | Acquired | 25,000 | $3.18 |
| 6 Jan 2026 | Catelani Michael | President, COO & CFO | A-Award | Acquired | 175,000 | $3.18 |
| 6 Jan 2026 | Baskies Arnold M | director | A-Award | Acquired | 25,000 | $3.18 |